Trial intelligence / Profile preview

Topical atorvastatin gel for diabetic foot ulcer

IRCT20100107003014N24Phase 3Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in diabetic foot ulcer (DFU) comparing Atorvastatin gel with Placebo gel (2 arms). Primary endpoints: Permanent pain, Change in ulcer grade and 1 more. Started Nov 2019; status: completed.

02

Drugs

atorvastatin
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on IRCT20100107003014N24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100107003014N24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call